2022
DOI: 10.1038/s41467-022-35059-x
|View full text |Cite
|
Sign up to set email alerts
|

EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis

Abstract: Triple-Negative Breast Cancer (TNBC) has a poor prognosis and adverse clinical outcomes among all breast cancer subtypes as there is no available targeted therapy. Overexpression of Enhancer of zeste homolog 2 (EZH2) has been shown to correlate with TNBC’s poor prognosis, but the contribution of EZH2 catalytic (H3K27me3) versus non-catalytic EZH2 (NC-EZH2) function in TNBC progression remains elusive. We reveal that selective hyper-activation of functional EZH2 (H3K27me3) over NC-EZH2 alters TNBC metastatic la… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 54 publications
(30 citation statements)
references
References 73 publications
0
30
0
Order By: Relevance
“…KRT14 is positively correlated with the metastasis of triple-negative breast cancer (TNBC), and deletion of KRT14 signi cantly reduces the migration, invasion, and peritoneal metastasis of TNBC [34]. KRT14 is absent in the distal airways of healthy lungs and plays an important role in the human pulmonary epithelial cells of IPF [35,36].…”
Section: Discussionmentioning
confidence: 99%
“…KRT14 is positively correlated with the metastasis of triple-negative breast cancer (TNBC), and deletion of KRT14 signi cantly reduces the migration, invasion, and peritoneal metastasis of TNBC [34]. KRT14 is absent in the distal airways of healthy lungs and plays an important role in the human pulmonary epithelial cells of IPF [35,36].…”
Section: Discussionmentioning
confidence: 99%
“…Epigenetic changes are gaining immense prominence as pivotal events in breast cancer progression and metastasis 28 . Our recent findings have revealed the role of epigenetic modulator EZH2 in reshaping the metastatic landscape of TNBC 29 . Additionally, there has been a growing comprehension regarding the crosstalk between metabolic reprogramming and epigenetic mechanisms during the course of cancer progression, epithelial to mesenchymal transition (EMT), and its subsequent metastasis 30, 31 .…”
Section: Introductionmentioning
confidence: 88%
“…All stained slides were examined under EVOS XL core microscope under 10X and 40X magnification. The staining intensity of each section was scored as described previously 29 where 0 (no staining), 1+ (weak staining), 2+ (moderate staining), or 3+ (strong staining). The tumor cell positive rate (0–100%) per slice was multiplied by the staining intensity to get an overall H-scores ranging from 0 to 300.…”
Section: Methodsmentioning
confidence: 99%
“…More surprisingly, recent study in mammalian showed that H3K27me3 was also involved in the promotion of gene expression. The deposition of H3K27me3 attenuates binding of repressor SP1 to the promoter of the target gene thus facilitating transcription [36]. EZH2, a H3K27me3 methylase, was revealed to be a transcription activator to activate gene expression but independent of its methyltransferase activity [37].…”
Section: The Unique Feature Of H3k27me3 Enrichment and Function In So...mentioning
confidence: 99%